MyFinsight
Home
Blog
About
Contact
Net income
$227,357K
Proceeds from short-term
loans
$58,204K
Proceeds from option
exercises and employee...
$23,875K
Share-based compensation
expenses
$123,355K
Depreciation and
amortization expense
$41,144K
Non-cash interest
expense
$21,096K
Other assets
-$15,270K
Other items, net
$6,172K
Other liabilities
$1,731K
Net cash provided by
operating activities
$201,336K
Net cash provided by
(used in) financing...
$68,632K
Canceled cashflow
$234,789K
Effect of foreign
exchange rate changes,...
$19,320K
Canceled cashflow
$13,447K
Net increase
(decrease) in cash, cash...
$243,778K
Canceled cashflow
$45,510K
Accounts receivable
$75,300K
Inventories
$71,838K
Accounts payable
-$42,187K
Amortization of research and
development cost share...
-$28,645K
Accrued expenses and
other payables
-$16,819K
Repayment of long-term
loan
$7,641K
Other financing
activities
-$3,249K
Repayment of sale of future
royalties liability
$2,557K
Proceeds from sale or
maturity of investments
$27K
Net cash used in
investing activities
-$45,510K
Canceled cashflow
$27K
Purchases of property,
plant and equipment
$40,789K
Other investing
activities
$4,748K
Back
Back
Cash Flow
BeOne Medicines Ltd. (ONC)
BeOne Medicines Ltd. (ONC)
source: myfinsight.com